Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Clinical trial NCT02391116 · COMPLETED

Trial details

NCT number: NCT02391116
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse, Large B-Cell, Lymphoma

Start date: 2015-05-08
Primary completion: 2016-07-05
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.